Categories: News

John Hinshaw Joins Digile as Strategic Advisor & Mentor to Accelerate AI-Led Growth and Global Expansion

SINGAPORE, Aug. 4, 2025 /PRNewswire/ — Digile, a leading digital transformation and AI solutions company headquartered in Singapore, announced the appointment of John M. Hinshaw as a Strategic Advisor. A seasoned global executive with over three decades of leadership at Fortune 100 companies – including Verizon Wireless, Boeing, Hewlett-Packard, and HSBC – Hinshaw brings a wealth of expertise in technology, operations, governance, and business transformation.

- Advertisement -

Over the course of his career, Hinshaw has held roles such as Group COO at HSBC, EVP of Technology and Operations at HP, CIO at Boeing, and SVP at Verizon Wireless. He currently serves on multiple public company boards and is a member of the Global Advisory Council at ServiceNow – where he first met the Digile team during their flagship Knowledge conference in Las Vegas.

- Advertisement -

“What drew me to Digile was not just their deep platform capabilities in ServiceNow, Salesforce, and Oracle, but their entrepreneurial mindset and agility,” said Hinshaw. “Their ability to help customers navigate both day-to-day operational challenges and forward-looking AI transformation puts them in a unique position. With a strong foundation in Asia and growing global reach, Digile is poised to make a significant impact.”

- Advertisement -

As an advisor, Hinshaw will help guide Digile’s strategy across three core dimensions: deepening customer value, expanding partnerships in the enterprise ecosystem, and identifying next-gen capabilities in AI, data, and quantum computing. With proven experience leading multi-billion-dollar operations and transformation programs, Hinshaw’s counsel is expected to catalyze Digile’s evolution into a trusted AI transformation partner for enterprises worldwide.

- Advertisement -

“John’s experience is unparalleled,” said Ravi Koka, CEO of Digile. “He has led digital and operational change at the highest levels and understands both the complexity and opportunity in today’s technology landscape. We are honored to have him onboard and excited for what lies ahead.”

- Advertisement -

Hinshaw emphasized that success in this new chapter will be measured not only by Digile’s growth but by its ability to deliver lasting value to clients. “In every role I’ve held, I’ve sought out partners who were not just capable but collaborative – who could grow with the business. Digile is exactly that kind of company,” he said.

- Advertisement -

About Digile

- Advertisement -

Founded in 2015, Digile is a Singapore-headquartered Digital & AI Technology Consulting company. Backed by Nomura, Digile offers end-to-end transformation services, helping enterprises modernize infrastructure, drive innovation, and scale with agility.

- Advertisement -

To learn more, visit: www.digile.com

- Advertisement -

Photo – https://mma.prnewswire.com/media/2743350/Image__10.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/john-hinshaw-joins-digile-as-strategic-advisor–mentor-to-accelerate-ai-led-growth-and-global-expansion-302520798.html

- Advertisement -

Recent Posts

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026…

6 hours ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI,…

6 hours ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing…

6 hours ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies

AlUla, Saudi Arabia, Feb. 7, 2026 /PRNewswire/ -- The second edition of the AlUla Conference…

6 hours ago

Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint…

6 hours ago

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

February 06, 2026 17:17 ET  | Source: Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, Feb. 06,…

6 hours ago